Biogen Idec Inc (NASDAQ:BIIB) | ISIS Pharmaceuticals’ and Biogen idec’s innovative collaboration voted breakthrough alliance of 2014

[PR Newswire] – CARLSBAD, Calif., April 30, 2014 /PRNewswire/ — Isis Pharmaceuticals, Inc. (ISIS) announced today that the strategic alliance between Isis and Biogen Idec (BIIB) has been honored with the Alliance 2014 . . . → Read More: Biogen Idec Inc (NASDAQ:BIIB) | ISIS Pharmaceuticals’ and Biogen idec’s innovative collaboration voted breakthrough alliance of 2014 Similar Articles: Market Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen Idec to Present New Two-Year Data from the PLEGRIDY™ (Peginterferon Beta-1a) Phase 3 ADVANCE Study at AAN Annual Meeting Company Update: Biogen Idec Inc (NASDAQ:BIIB) – Biogen Idec to Present New Clinical Data from Its Robust Neurology Portfolio at AAN Annual Meeting Stock Update (NASDAQ:BIIB): Biogen Idec to Report First Quarter 2014 Financial Results on April 23, 2014